TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | Time CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
UPSC | Exam ScheduleExam Mentor
Don't Miss
Advertisement

Health minister Mansukh Mandaviya reviews Covid crisis in North-East

Tribune News Service New Delhi, August 17 Union Health Minister Mansukh Mandaviya on Tuesday visited Assam to review the Covid-19 surge in the northeastern states, which are contributing a significant portion of the new infections after Kerala, which is contributing...
Advertisement

Tribune News Service

Advertisement

New Delhi, August 17

Advertisement

Union Health Minister Mansukh Mandaviya on Tuesday visited Assam to review the Covid-19 surge in the northeastern states, which are contributing a significant portion of the new infections after Kerala, which is contributing half the load.

“Reviewed the pandemic situation, vaccination and implementation of the emergency Covid response package II in the North-Eastern states, along with Health Ministers of North-Eastern states. The government has announced the emergency package to support the states in fighting Covid and eight states of the North-Eastern region have been sanctioned Rs 1,352.92 crore,” Mandaviya said.

He assured the states that the Central Government would continue to give all possible help and urged them to expedite the implementation of the ECRP-II package.

Advertisement

“This package will help to create the necessary infrastructure for Covid testing, medicine storage, beds, paediatric units, ventilators and oxygen storage, among other medical facilities,” he added.

SII acquires 50% stake in vial-making firm

The Serum Institute of India on Monday announced acquisition of 50% stake in SCHOTT Kaisha, the largest vial makers, with a view to expand its capacities to meet Covid-19 vaccine production targets by securing pharma packaging supply.

Advertisement
Show comments
Advertisement